FDA Pushes Clinical Trial Transparency in 2026
Nearly 30% of clinical trials required to report results never submitted data to ClinicalTrials.gov, prompting FDA enforcement letters in April 2026.
7 articles tagged "clinical trials"
Nearly 30% of clinical trials required to report results never submitted data to ClinicalTrials.gov, prompting FDA enforcement letters in April 2026.
Revolution Medicines' daraxonrasib nearly doubled median survival in metastatic pancreatic cancer patients compared to chemotherapy, according to new data.
Authors respond to correspondence questioning FLUNITY-HD1 trial design and whether high-dose influenza vaccine offers clear clinical benefits in older adults.
Sarepta Therapeutics shares rose 20% after releasing early clinical data for two rare muscle-wasting disease candidates, SRP-1001 and SRP-1003.
Pfizer and Valneva's Lyme disease vaccine reduced infection risk by over 70%, but failed to meet its prespecified statistical threshold in clinical trials.
ARPA-H is advancing FDA-authorized AI clinical tools in 2026, pairing federal research funding with mandatory clinical trial validation and deployment pathways.
Structure Therapeutics reports 16% weight loss in Phase 2 oral GLP-1 trial, plus GSK's Arexvy expansion and new cholesterol guideline updates.